XtalPi, an AI drug discovery and development company, closed a $318.8 million oversubscribed Series C funding co-led by SoftBank Vision Fund2, PICC Capital and Morningside. The company uses its expertise in chrystal structures plus quantum physics, AI and cloud computing to develop new drugs. XtalPi's model combines physics-based concepts with data from labs. Because the three founders met at MIT, the company's headquarters are in Cambridge , MA , though its computational R&D center and experimental center are in Shenzhen. More details.... Share this with colleagues: // //